← FDA Drug Approvals (Drugs@FDA)
BEXAROTENE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2020-06-16
Drug application
- FDA Application #
ANDA203663- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BEXAROTENE
- Generic name
- Bexarotene
- Active ingredients
- BEXAROTENE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- HIKMA
- First approval
- 2020-06-16
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown